Neuphoria Therapeutics
NEUP
#9921
Rank
S$22.79 M
Marketcap
$6.74
Share price
0.38%
Change (1 day)
-57.95%
Change (1 year)

Neuphoria Therapeutics (NEUP) - Cash on Hand

Cash on Hand as of December 2024 : S$5.69 Million

According to Neuphoria Therapeutics's latest financial reports the company has S$5.69 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neuphoria Therapeutics - Cash on Hand chart (from 2022 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30S$17.1 M57.41%
2023-06-30S$10.86 M-66.21%
2022-06-30S$32.15 M48.63%
2021-06-30S$21.63 M618.33%
2020-06-30S$3.01 M-68.86%
2019-06-30S$9.67 M-48.8%
2018-06-30S$18.88 M-46.57%
2017-06-30S$35.34 M2.3%
2016-06-30S$34.55 M60.81%
2015-06-30S$21.48 M84.69%
2014-06-30S$11.63 M-50.97%
2013-06-30S$23.73 M3.06%
2012-06-30S$23.02 M1.8%
2011-06-30S$22.61 M79.24%
2010-06-30S$12.61 M181.65%
2009-06-30S$4.48 M-42.72%
2008-06-30S$7.82 M-44.62%
2007-06-30S$14.12 M242.52%
2006-06-30S$4.12 M-53.29%
2005-06-30S$8.82 M22.07%
2004-06-30S$7.23 M50.79%
2003-06-30S$4.79 M-0.07%
2002-06-30S$4.79 M710535.88%
2001-06-30S$0 M-99.79%
2000-06-30S$0.32 M401.94%
1999-06-30S$0.06 M